Since 2018, Biozenta delivers affordable, research-driven oncology and critical care medicines — improving lives globally with innovation, trust, and world-class quality.
Years Of Experience
Trusted By
Oncology
Critical Care
API Development
Research & Innovation
Manufacturing
Quality Control
Global Presence
Regulatory Support
Sustainability
Oncology
Critical Care
API Development
Research & Innovation
Manufacturing
Quality Control
Global Presence
Regulatory Support
Sustainability
Biozenta has laid its foundation in year 2018 with a noble intention to provide critical care medicines at an affordable cost enabling every human being to live healthier, happier and more active life.
In short, span of time, Biozenta became a trusted name in global pharmaceutical industry as a leading manufacturer of best quality product in Oncology and critical care segment.
Working with international healthcare leaders and research institutions.
Learn More
Dr. Deep Narayan Sharma, Founder and Managing Director of Biozenta group of companies is a sound technocrat and young, ambitious and dynamic leader. Completed his masters in pharmacy with MBA in Production Management having vast and sound experience in the field of Pharmaceutical manufacturing industry, is a first-generation entrepreneur of his family with lot of passion, focused approach and deep understanding of Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products with major focus on nano-particles and Liposomal technologies.
With 22+ years of experience in corporate industry at various levels including top management and his passion for Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products, he started his first venture in the year 2011 as Dr. Aarbidee Laboratories and Aarya Healthcare (A Division for Food Products) which has been later merged with Biozenta group in 2018.
Under the guiding principles and leadership of Dr. Deep Narayan Sharma, Biozenta achieved various new milestones and offered many innovative Oncology, Anti-cancer, Cytotoxic, Critical Care and Life Saving products.
Firm believer in hard work, self-belief, “walk the talk”, leading by examples, ambitious, innovative approach, “passion for work” are some of the key success factors which he wants to imbibe by every employee of the organization to achieve company’s vision of “Human Helping Human”
Our research is powered by expert teams and state-of-the-art technologies, ensuring precision, innovation, and real-world impact. Each field is explored with curiosity, guided by data, and focused on delivering meaningful solutions.
Advanced cancer-focused therapies and medicines ensuring better patient outcomes.
Comprehensive solutions for intensive care and life-saving treatments.
High-quality Active Pharmaceutical Ingredients for global healthcare needs.
Cutting-edge research driving continuous innovation in pharmaceuticals.
Biozenta Lifescience is committed to providing affordable, high-quality medicines in Oncology, Critical Care, APIs and General Injectables. With state-of-the-art manufacturing and DSIR approved R&D, we serve patients across 30+ countries with innovative and life-saving medicines.
Supplying to Asia, Africa, Europe, LATAM & GCC with strong regulatory approvals.
Manufacturing world-class Oncology, Anti-Cancer and Critical Care formulations including Injectables, Lyophilized, PFS, Tablets & Capsules.
WHO-cGMP, PICs approved and EU GMP approvable plants located in Una, Himachal Pradesh with dedicated Oncology and API units.
DSIR approved R&D labs specializing in formulation development, APIs and advanced technologies like Nano-particles, Liposomes & Monoclonal Antibodies.
Exporting to 30+ countries worldwide with 180+ international registrations and strong global collaborations.
Providing innovative, affordable oncology solutions to improve cancer care worldwide.
Supplying trusted general medicines that enhance everyday health and patient well-being.
Delivering safe, reliable injectable medicines for faster and effective therapeutic results.
Offering effective, patient-friendly tablets designed for consistent treatment and better compliance.
Manufacturing quality capsules to provide accurate dosage and improved patient satisfaction.
Biozenta Lifescience is a trusted name in the pharmaceutical industry with a strong presence across Oncology, Critical Care, APIs and General Injectables. With WHO-cGMP certified, PICs approved facilities and DSIR approved R&D, we deliver life-saving medicines that meet international standards.
Supplying to 30+ countries with 180+ product registrations across Asia, Africa, Europe, LATAM & GCC.
State-of-the-art WHO-cGMP certified and EU GMP approvable plants at Una, H.P. with dedicated Oncology and API units.
DSIR approved R&D labs and expertise in Nano-particle, Liposomal & Monoclonal Antibody technologies.
Biozenta, a Indian Global Multinational Company:
Biozenta exports to 30+ countries across Asia, Africa, LATAM, CIS, MENA, and Europe, with 180+ international product registrations and many more underway. Actively participating in Govt, MOH, and local tenders worldwide, Biozenta is among the fastest-growing Indian pharmaceutical manufacturers and exporters.
Commitment to Quality
We aim to be a world-class pharmaceutical company delivering high-quality, affordable products. Our R&D and regulatory teams focus on innovative generics across multiple therapeutic categories—Oncology, Anti-cancer, Critical Care, Injectables, Oral Solids, ARVs, Derma, Cosmetics, and APIs.
